Your browser doesn't support javascript.
loading
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia.
Zavorka Thomas, Megan E; Jeon, Jae Yoon; Talebi, Zahra; Buelow, Daelynn R; Silvaroli, Josie; Campbell, Moray J; Sparreboom, Alex; Pabla, Navjot; Baker, Sharyn D.
Afiliação
  • Zavorka Thomas ME; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Jeon JY; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Talebi Z; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Buelow DR; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Silvaroli J; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Campbell MJ; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Sparreboom A; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Pabla N; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
  • Baker SD; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH.
Blood Adv ; 5(23): 5041-5046, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34614509

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article